Consistent policies urged

KARACHI: Dr Imran Ahmad Khan, CEO Bayer Pakistan on Wednesday called for consistent and transparent implementation of policies to enable the pharma industry provide research-based products along with employment opportunities, transfer of technology and to boost exports.

“As a multinational life science company committed to advancing quality healthcare and nutrition in Pakistan, we look to the government and regulatory stakeholders to work with us to create a positive, supportive regulatory environment that increases the ease of doing business,” said Khan said in statement.

Khan said technology transfer is an important area where multinational pharmaceuticals can positively boost the industry through contract manufacturing, if enabled by a change in regulation by government to do so.

“Contract manufacturing allows for the high production and quality-control standards of multinationals to be adopted by local contract manufacturers, effectively contributing to raising the bar on the industry overall.”

He suggested that amendments in the regulatory framework to expedite registrations of pharmaceutical products will enable pharmaceutical companies to help the government address major challenges in healthcare in a timely manner.